Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10094 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10094 To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES August 13, 2026 Ms. Hoyle of Oregon (for herself, Mr. Doggett, Ms. Stansbury, Mr. Takano, Ms. Norton, Ms. Tlaib, Ms. Jayapal, and Mr. Casar) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Affordable Pricing for Taxpayer- Funded Prescription Drugs Act of 2026''. SEC. 2. REASONABLE PRICE AGREEMENT. (a) In General.--All Federal agencies providing or receiving research funding, through a grant, contract, cooperative agreement, or other agreement, shall require in such agreement, and in any license of the rights to a patent or regulatory test data for a biomedical product or service, that the price of any biomedical product or service developed with the benefit of such research be reasonable (as determined by the Secretary) unless the Secretary waives such reasonable price obligation under subsection (d). (b) Prohibition Against Charging Prices Higher Than in Other Large Economies With High Incomes.-- (1) In general.--For purposes of subsection (a), any reasonable pricing formula
← Back to Gregorio Casar's profile